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Abstract
Background: There is a marked paucity of data concerning AKI in Sub-Saharan Africa, where there is a substantial
burden of trauma and HIV.
Methods: Prospective data was collected on all patients admitted to a multi-disciplinary ICU in South Africa during
2017. Development of AKI (before or during ICU admission) was recorded and renal recovery 90 days after ICU
discharge was determined.
Results: Of 849 admissions, the mean age was 42.5 years and mean SAPS 3 score was 48.1. Comorbidities included
hypertension (30.5%), HIV (32.6%), diabetes (13.3%), CKD (7.8%) and active tuberculosis (6.2%). The most common
reason for admission was trauma (26%). AKI developed in 497 (58.5%). Male gender, illness severity, length of stay,
vasopressor drugs and sepsis were independently associated with AKI. AKI was associated with a higher in-hospital
mortality rate of 31.8% vs 7.23% in those without AKI. Age, active tuberculosis, higher SAPS 3 score, mechanical
ventilation, vasopressor support and sepsis were associated with an increased adjusted odds ratio for death. HIV
was not independently associated with AKI or hospital mortality. CKD developed in 14 of 110 (12.7%) patients with
stage 3 AKI; none were dialysis-dependent.
Conclusions: In this large prospective multidisciplinary ICU cohort of younger patients, AKI was common, often
associated with trauma in addition to traditional risk factors and was associated with good functional renal recovery
at 90 days in most survivors. Although the HIV prevalence was high and associated with higher mortality, this was
related to the severity of illness and not to HIV status per se.
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Background
Acute Kidney Injury (AKI) is commonly encountered in
the Intensive Care Unit (ICU) [1], but with a widely vari-
able reported incidence due to non-standardization of its
definition [2]. Regardless of the definition used, AKI is a
well-recognized independent risk factor for mortality, is
associated with substantial morbidity and is a current
major cause for global concern [3–6]. Furthermore, AKI
requiring dialysis is now recognized as a risk factor for
end stage kidney disease in the long term [7, 8] and is
associated with poor long-term quality of life after ICU
discharge [9, 10].
AKI has been well characterized in high income (HI)
countries and appears to be increasing in incidence [5,
11–13]. However, there is a marked paucity of data from
African ICU’s concerning the incidence, aetiology and
effect of AKI on mortality and functional renal recovery,
where the prevalence of HIV and trauma is high and
where resources are often limited [6, 14, 15]. Renal re-
placement therapy is an expensive [16] and scarce re-
source in South Africa [17] and in particular, in the rest
of sub-Saharan Africa [18, 19].
The International Society of Nephrology has boldly
called for 0by25: The elimination of preventable deaths
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from AKI by 2025 [20]. Timely diagnosis and prevention
remain the most important strategies. Accordingly, un-
derstanding the epidemiology of AKI in lower and mid-
dle income (LMI) countries must be a key step in
tackling this problem. Our aim therefore, was to de-
scribe the epidemiology of AKI in patients admitted to
our South African multidisciplinary ICU, where there is
currently a high prevalence of HIV and trauma-
associated admissions. We sought to characterize the
factors associated with the development of AKI, the ef-
fect of HIV on AKI as well as survival and to report on
the 90-day renal function outcome of all who developed
AKI.
Methods
Study design and setting
An observational prospective design was used. Cohorts
were divided into those who did and did not develop
AKI (prior to and/or after admission to the ICU) as well
as by HIV status where known. All patients older than
12 years admitted to the Livingstone Hospital ICU be-
tween 3 January 2017 and 3 January 2018 were included.
Patients who died within 6 h of being admitted to ICU,
those who were brain-dead awaiting organ harvesting,
and patients with known or presumed end stage kidney
disease were excluded from the study.
The Livingstone Hospital adult ICU is a tertiary ser-
vice, closed, multi-disciplinary 16-bed unit serving a
catchment area of 1.6 million people. The hospital is
government-funded and is located in the Nelson Man-
dela Bay Metropole in South Africa where 1.15 million
people live in an urban setting, 12.3% of whom live in
informal shack dwellings and 36.6% of whom are un-
employed. The balance of 450,000 people live in sur-
rounding rural areas within a radius of 250 km [21]. Full
time consultant supervision is provided by two intensi-
vists and two nephrologists. The provision of dialysis is
also government-funded and not restricted within the
ICU or by HIV status. However, general prognosis and
current resource limitations are taken into consideration
prior to the admission of any patient to the ICU [22].
The modality of dialysis is chosen by the treating con-
sultant based on clinical status with a preference for
intermittent haemodialysis or sustained low efficiency
daily dialysis (SLEDD) due to cost constraints. Continu-
ous renal replacement therapy (CRRT) is reserved for se-
verely haemodynamically unstable patients and for those
with raised intracranial pressure. Referring disciplines
include medicine, trauma, general surgery, urology,
neurosurgery, orthopaedics, obstetrics and gynaecology.
Elective cardiology and cardio-thoracic surgery have
their own dedicated ICU. Obstetrics also has their own
high care although patients with advanced organ dys-
function are referred to our unit.
Definition of acute kidney injury
AKI was diagnosed and staged according to the Kidney
Diseases Improving Global Outcomes (KDIGO) defin-
ition [23]. A normal serum creatinine not older than 90
days was assumed to be the baseline where available, as
recommended [24]. The cause of AKI was determined
by the treating intensivist/nephrologist and more than
one cause could be assigned.
Definition of outcomes
AKI was recorded as resolved once creatinine improved
to the known or presumed baseline. If renal function
had not recovered by hospital discharge, patients were
followed up for at least 90 days following ICU discharge
or until renal recovery. Patients who had not recovered
their renal function by this time were deemed to have
chronic kidney disease (CKD).
Ethical approval
Approval for the study (protocol number: 067/2016) was
granted by the Walter Sisulu University Human Re-
search Ethics Unit. Since we were conducting a non-
experimental study that would not influence clinical
decision-making or patient management, the need for
study participant consent was waived by the Ethics Unit.
Data collection and management
Demographic data including age, sex, race and details re-
lated to co-morbidities were recorded. For patients
known with HIV, a premorbid CD4 count and viral load
was recorded, where available. The Simplified Acute
Physiology Score 3 (SAPS 3) [25] was calculated within
the first hour of ICU admission. The Sequential Organ
Failure Assessment (SOFA) [26] was calculated 24 h
after admission and every third day thereafter, or sooner
if the patient’s condition deteriorated. Vasopressor and
mechanical ventilation requirements were also recorded.
Cause of AKI, renal replacement modality and creatinine
on admission, peak and discharge were recorded for pa-
tients in the AKI cohort. Sepsis was defined using
Sepsis-3 criteria [27].
Statistical analysis
Data were exported from the Research Electronic Data
Capture (REDCap) hosted at the University of Cape
Town [28] and analyzed with RStudio, 2017 (Version
3.4.2). Hypothesis tests were considered significant if the
two-sided p-value < 0.05. Continuous data were tested
for normality using the Kolmogorov-Smirnov, Shapiro-
Wilk, Anderson-Darling and Pearson’s chi-squared tests.
Normally distributed data are reported as means (stand-
ard deviation) and skewed data as medians (interquartile
range). Discrete data are presented as numbers (percent-
ages). The student’s t-test and the Mann-Whiteney U
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test were used to compare continuous data and the Chi-
square and Fischer’s exact test were used for discrete
data, as appropriate. Missing outcome data (n = 12) were
analysed using multiple imputation. Hazard ratios for
mortality by AKI and HIV status were calculated using
the Cox proportional hazards model. Multivariate
logistic-regression models were used to determine asso-
ciations of developing AKI and dying. Variables by bi-
variate analysis with an alpha level < 0.1 between AKI
and non-AKI cohorts as well as known predictors for
AKI (age, sex, hypertension, active malignancy and ad-
mission SAPS 3 score) were included in the model.
KDIGO stages 1, 2 and 3 were compared to patients
who did not develop AKI as reference.
Results
A total of 875 patients were admitted to the ICU
during the study period and 26 were excluded from
the analysis; Fig. 1 details the reasons for exclusion.
Vital status after ICU discharge could not be estab-
lished for 12 patients due to in-patient transfers to
other hospitals and the unavailability of further re-
cords; six were in the AKI cohort, and outcomes
were imputed.
In-hospital mortality was 21.6% while mortality in
ICU was 13.4%. The most common diagnoses admit-
ted were: Assault (14%), motor and pedestrian vehicle
accidents (12%), acute abdomen (10%), pneumonia
(6%; including cases later identified as tuberculosis)
and self-inflicted drug/toxin overdose (3.5%). Admis-
sions included surgical emergencies (n = 451, 53.1%),
medical emergencies (n = 261, 30.7%), surgical
elective cases (n = 110, 13%) and obstetric emergen-
cies (n = 27, 3.2%). Table 1 shows the baseline char-
acteristics of all patients admitted to the ICU and by
AKI status.
Severity and causes of AKI
AKI developed in 497 patients (58.5%), 80.5% of whom
were diagnosed with AKI on admission to the ICU. The
maximum KDIGO stage was stage 1 in 138 (27.7%),
stage 2 in 152 (30.6%) and stage 3 in 207 (41.7%) pa-
tients respectively.
Figure 2 shows the main causes identified for devel-
oping AKI. Herbal ingestion was only documented in
4 patients and 12 patients were exposed to anti-
tuberculous drugs (rifampicin and isoniazid). Of the
105 HIV positive patients who developed AKI, 24 had
received tenofovir prior to AKI diagnosis. Histology
was obtained in situations where the cause of AKI
was not clear or the clinical course of the patient was
unclear. Kidney biopsies were performed in 5 patients
(1% of the AKI cohort), only 1 of whom had HIV
which showed interstitial HIV associated nephropathy.
The others were in HIV negative subjects; 3 showed
features of mesangiocapillary glomerulonephritis, 1 of
which was crescentic and 1 had features of ascending
pyelonephritis.
Risk factors associated with AKI
Risk factors associated with AKI are presented in
Table 2. On multivariate analysis, male gender,
increased SOFA and/or SAPS 3 score, increased
length of stay, the need for vasopressor drugs and
Fig. 1 Diagram of patients included in the analysis
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the development of sepsis or septic shock were inde-
pendently associated with the development of AKI
by logistic-regression modeling. HIV was not inde-
pendently associated with AKI.
Use of renal replacement
Eighty-eight patients were dialyzed (42.5% of patients
with stage 3 AKI, 18.0% of the cohort with AKI and
10.4% of the entire cohort), 67.0% of whom were
Table 1 Baseline characteristics of all patients admitted to the ICU
Characteristic All patients n = 849 AKI n = 497 No AKI n = 352 p-value
Demographics
Mean age, yearsa (SD) 42.5 (16.8) 43.7 (16.8) 40.9 (16.6) 0.017
Male gendera % 58.9 61.2 55.7 0.110
Racea %
Black African 58.0 60.5 54.3 0.067
Mixed Ancestry 27.4 26.0 29.6 0.248
BCaucasian 13.8 12.7 15.3 0.267
Other 0.8 0.8 0.8 0.827
Co-morbidities
Diabetesa % 13.2 16.1 9.1 0.003
Mean HbA1c % (SD) 9.9 (3.2) 10.3 (3.1) 9.1 (3.3) 0.142
Hypertensiona % 31.6 32.2 30.7 0.641
Ischaemic heart disease % 4.2 4.6 3.7 0.506
Active Tuberculosis % 6.1 6.6 5.4 0.457
Chronic kidney diseasea % 7.7 6.4 9.4 0.113
Mean CKD eGFR (SD) 32 (19) 40 (16) 21 (1) < 0.001
Epilepsy % 4.8 5.0 4.6 0.746
Malignancya % 3.3 3.6 2.8 0.530
HIV
Known status, n = 472 (56.1%)
Positive, n (%) 155 (32.6) 105 (35.1) 50 (28.3) 0.010
Negative, n (%) 321 (67.4) 194 (64.9) 127 (71.8) 0.382
In HIV positive cohort:
Median CD4 count, cells/μL (IQR) 318(156–493) 205 (119–391) 404 (308–513) 0.025
Median viral load, log (IQR) 2.0 (1.98–4.04) 2.0 (1.88-3.62) 2.5 (2.00–4.64) 0.234
Receiving HAARTa % 11.9 14.5 8.2 0.006
Severity of illness
Emergency admissions % 87.0 92.8 79.0 < 0.001
Mean SAPS 3 scorea (SD) 48.1 54.0 39.7 < 0.001
Median highest SOFA scorea (IQR) 4 (1–6) 6 (3–9) 2 (1–4) < 0.001
Sepsis and septic shocka % 30.2 43.1 11.9 < 0.001
Ventilateda % 53.7 64.8 38.2 < 0.001
median ventilator days (IQR) 3 (1–7) 3 (1–8) 2 (1–4) < 0.001
Required vasopressorsa % 25.0 38.8 5.4 < 0.001
ARDSa % 4.4 6.8 0.9 < 0.001
Median ICU days (IQR) 3 (1–6) 4 (2–8) 2 (1–4) < 0.001
ICU length of stay > 7 daysa % 24.7 33.2 12.8 < 0.001
Deceased in ICU % 13.0 20.5 2.3 < 0.001
Abbreviations: AKI Acute Kidney Injury, CI Confidence interval, SD Standard deviation, IQR Interquartile range, CKD Chronic Kidney Disease, eGFR Estimated
Glomerular Filtration Rate, HAART Highly Active Antiretroviral Therapy, SAPS 3 Simplified Acute Physiology Score 3, SOFA Sequential Organ Failure Assessment,
ARDS Acute Respiratory Distress Syndrome. aVariables included in multivariate analysis
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initiated within 24 h of arrival to ICU. Intermittent
haemodialysis was used in most (80.7%; Fig. 3). The
most common indications for dialysis initiation were
life-threatening hyperkalaemia (44.3%), uraemic symp-
toms such as encephalopathy or seizures (34.1%) and re-
fractory metabolic acidosis (34.1%).
Mortality and AKI
The development of AKI was associated with a higher
in-hospital mortality rate of 31.8% compared to 7.2% in
those without AKI (Hazards Ratio 4.07, 95% CI 2.66;
6.21; logrank p < 0.001 (Fig. 4)). Further, the odds of
dying increased stepwise with increasing KDIGO AKI
stage (Fig. 5). The absolute in-hospital mortality rate was
29/134 (21.6%), 39/150 (26.0%) and 87/206 (42.2%) in
stage 1, 2 and 3 AKI respectively and 32/88 (36.4%)
for those who received dialysis. In those receiving
exclusively intermittent haemodialysis, mortality was
31.0% compared to 55.5 and 62.5% for those who
received exclusively SLEDD or CRRT, respectively
[adjusted OR (95%CI) for CRRT: 6.59 (1.55; 27.88);
p-value 0.01].
Fig. 2 Identifiable causes of AKI. A pre-renal aetiology (such as hypovolaemic shock) was identified in 55.1%, sepsis in 40.6% and rhabdomyolysis,
usually related to trauma, in 24.8%. “Other” included obstructive uropathy, direct drug nephrotoxicity, hypertensive crisis, thrombotic
microangiopathy, and rapidly progressive glomerulonephritis. More than one cause may have been implicated in the same patient, especially if
the patient developed more than one episode of AKI during the same admission
Table 2 Crude and Adjusted odds ratios determined by multivariate analysis exploring risk factors associated with AKI
Crude odds ratio (95%CI) Adjusted odds ratio (95%CI) p-value
Age, per 10 year increase 1.10 (1.002; 1.018) 1.11 (0.999; 1.260) 0.079
Male gender 1.22 (0.92; 1.608) 1.44 (1.008; 2.058) 0.045
Diabetes 1.88 (1.228; 2.945) 1.69 (0.982; 2.947) 0.059
Baseline CKD 0.64 (0.382; 1.066) 0.32 (0.163; 0.634) 0.001
Receiving HAART 1.95 (1.245; 3.137) 1.64 (0.940; 2.920) 0.086
Admission SOFA score 1.48 (1.391; 1.585) 1.33 (1.215; 1.456) < 0.001
SAPS 3 score 1.07 (1.062; 1.088) 1.03 (1.013; 1.047) < 0.001
ICU length of stay, days 1.12 (1.081; 1.155) 1.04 (1.007; 1.072) 0.026
Required mechanical ventilation 3.05 (2.299; 4.072) 0.56 (0.359; 0.860) 0.003
Required vasopressors 11.15 (6.954; 18.878) 2.52 (1.392; 4.700) 0.003
Developed ARDS 12.39 (3.734; 76.752) 3.20 (0.840; 21.071) 0.137
Developed sepsis or septic shock 5.50 (3.839; 8.038) 1.81 (1.119; 2.929) 0.016
HIV Infectiona 1.42 (0.952; 2.15) 0.60 (0.272; 1.305) 0.198
Abbreviations: HAART Highly Active Antiretroviral Therapy, SOFA Sequential Organ Failure Assessment, SAPS 3 Simplified Acute Physiology Score 3, ARDS Acute
Respiratory Distress Syndrome. a Analysis restricted to only those with a known HIV serostatus (n = 472)
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In the AKI cohort, an increased adjusted odds ratio for
death was observed with increasing age, active tuberculosis,
higher SAPS score, receipt of mechanical ventilation, receipt
of vasopressor support and in those with sepsis (Table 3).
HIV infection was associated with worse survival in
those with AKI (Fig. 6). However, on multivariate ana-
lysis, HIV was not found to be an independent risk fac-
tor for mortality (Table 3). Patients with HIV and AKI
were more severely ill on admission with mean SAPS 3
score (SD) of 58.2 (15.9) versus 53.3 (13.8), p = 0.007
and SOFA (IQR) of 8 (4; 11) versus 6 (3; 9), p = 0.01.
They also had a higher likelihood of having active tuber-
culosis [OR (95%CI) = 3.55 (1.42; 9.36), p = 0.008]. The
median premorbid CD4 count was significantly lower in
those with AKI than without (204.5 cells/microliter ver-
sus 404 cells/microliter, p = 0.025) but viral suppression
was similar in both groups (viral load log 2.0 vs 2.5 re-
spectively, p = 0.234). Although ICU length of stay was
less in HIV patients with AKI (median ICU days 3 vs 6,
p = 0.002), the proportion of patients with HIV who died
within the first 24 h was higher at 10.5% compared to
2.6% in those who were HIV negative, p = 0.009.
Fig. 3 The relationship between modes of renal replacement that were usedAbbreviations: CRRT, Continuous Renal Replacement Therapy; IHD,
Intermittent Haemodialysis; SLEDD, Sustained Low Efficiency Daily Dialysis.
Fig. 4 Kaplan Meier plot showing survival probability for patients following ICU admission who developed AKI and those that did not
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Fig. 5 The odds of dying for increasing KDIGO stage of severity
Table 3 Multivariate analysis for predictors of mortality in the AKI cohort (n = 497)
Covariate Crude odds ratio (95% CI) Adjusted odds ratio (95% CI) p–value
Age, per 10 year increase 1.16 (1.030; 1.300) 1.33 (1.12; 1.59) 0.002
Gender (male) 0.88 (0.596; 1.296) 0.96 (0.584; 1.588) 0.878
Diabetes 0.8 (0.462; 1.348) 0.47 (0.223; 0.963) 0.043
Active malignancy 0.82 (0.259; 2.218) 1.03 (0.25; 3.782) 0.963
Active tuberculosis 2.14 (1.042; 4.370) 2.84 (1.14; 7.079) 0.025
CKD 0.87 (0.372; 1.880) 1.12 (0.357; 3.331) 0.840
Hypertension 1.1 (0.733; 1.665) 1.47 (0.790; 2.81) 0.224
Receiving HAART 0.99 (0.585; 1.719) 1.37 (0.670; 2.88) 0.398
SAPS 3 score 1.07 (1.054; 1.089) 1.04 (1.026; 1.065) < 0.001
ICU days 0.99 (0.971; 1.010) 0.96 (0.929; 0.985) 0.004
Mechanical ventilation 5.00 (3.087; 8.420) 2.08 (1.084; 4.062) 0.029
Requiring vasopressors 7.26 (4.782; 11.182) 3.99 (2.318; 6.961) < 0.001
ARDS 1.43 (0.678; 2.930 0.82 (0.335; 1.973) 0.661
Sepsis 3.15 (2.127; 4.686) 1.8 (1.047; 3.083) 0.033
HIV statusa 1.76 (1.05; 2.94) 1.11 (0.56; 2.15) 0.769
aAnalysis restricted to only those with AKI and a known HIV status (n = 296). See survival analysis for HIV-AKI cohort in Fig. 6.
Abbreviations: HAART Highly Active Antiretroviral Therapy, SAPS 3 Simplified Acute Physiology Score 3, ARDS Acute Respiratory Distress Syndrome
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Renal recovery from AKI
Functional renal recovery was assessed at 90 days
after hospital discharge in patients with AKI who
survived (n = 332): Full recovery occurred in 236
(100%) of those who developed maximum KDIGO
stage 1 or 2 AKI and 96 of 110 (87.3%) who devel-
oped stage 3 AKI. CKD was therefore established in 14
patients (12.7% of survivors) with a median creatinine
(IQR) of 175 (137; 424) μmol/L. Non-recovery of renal
function in survivors was associated with a higher admis-
sion creatinine (670 vs 257 μmol/L; p-value 0.004) and re-
ceiving dialysis (64.3% vs 32.3%, p = 0.043), but not with
admission severity score (SAPS 3 admission score = 55.1
versus 56.1, p = 0.811), premorbid creatinine values
(76 μmol/L; IQR 60; 228 versus 76umol/L; IQR 56; 130,
p = 0.796) nor receiving prolonged dialysis modalities like
SLEDD and CRRT (44.4% versus 29.03% respectively, p =
0.667). The group that did not recover was less likely to
have pre-renal failure (14.3% versus 51.0%, p = 0.022) as a
cause for AKI. This group also tended to have more dia-
betes (35.7% vs 15.6%, p = 0.069) and hypertension (57.1%
vs 31.3%, p = 0.057), a lower CD4 count if HIV positive
(55, IQR 45; 65, vs 165, IQR 131; 312; p = 0.067) and a
higher HIV viral load (log 4.06 vs log 1.94, p = 0.247). HIV
infection itself and the receipt of HAART was not associ-
ated with non-recovery of renal function in survivors, p =
0.972 and 0.886 respectively. No patients were dialysis
dependent at 90-days.
Other differences between HIV positive and negative
patients with AKI
HIV positive patients with AKI were more likely to be of
Black African ethnicity (85.7% vs 59.2%, p < 0.001), to be
an emergency admission (92.4% vs 23.0%, p < 0.001), to
have a medical rather than surgical problem (73.3% vs
26.2%, p < 0.001), to have sepsis (41.3% vs 32.1%, p =
0.049) and to have active tuberculosis (15.5% vs 6.85%,
p < 0.003).
Discussion
This is the largest prospective African study of AKI in
critically ill adults with an HIV seropositive rate of
32.6%. Similar studies include reports from Morocco
(n = 97) [29], the Democratic Republic of Congo (DRC,
n = 476) [30] and Egypt (n = 532) [31]. However, only
the DRC study reported HIV prevalence, which was low
at 2.9%. Consistent with other LMI countries, patients
were younger than in HI country cohorts (mean age 40.6
years) with lower comorbidity rates [1, 18, 19, 29–32],
mostly of Black African ethnicity, and were representative
of the local community that we serve [21].
As in other African [29–31] and HI country [1] ICU-
based studies, AKI was very common in our cohort and
affected nearly two thirds (58.5%) of all patients admit-
ted to the ICU. AKI was associated with male gender,
higher severity of illness, more sepsis, longer ICU stay
and the need for vasopressors. Pre-existing CKD was
Fig. 6 Kaplan Meier plot showing the association between survival probability by HIV status for those with AKI, Hazard ratio (95%CI) = 1.8 (1.18;
2.74). The analysis was restricted to only those with AKI and a known HIV status (n = 296)
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negatively associated with AKI but reflects an admission
bias against very ill patients with CKD to the unit due to
a lack of resources to continue with chronic renal re-
placement therapy in most. Increased age, severity of
illness, sepsis, mechanical ventilation, the use of vaso-
pressors and the presence of tuberculosis were inde-
pendently associated with mortality in those with AKI.
Furthermore, increasing stage of AKI showed a stepwise
increase in the risk of mortality.
Although our unit admits emergency medical as well
as elective surgical cases, just over a quarter of all admis-
sions were trauma related, reflecting the alarmingly high
levels of interpersonal violence and road traffic accidents
prevalent in South Africa. In 2010, interpersonal vio-
lence and road injury combined were the second leading
cause of death and disability adjusted life years lost in
South Africa, after HIV which was the leading cause
[33]. Consequently, a large proportion of AKI was attrib-
utable to hypovolaemic shock (55.1%) and rhabdomyoly-
sis (24.8%) in keeping with the degree of trauma-related
admissions. Two recent retrospective studies in South
Africa also highlighted AKI in trauma victims as a major
contributor to morbidity and mortality [34, 35]. This re-
flects a major change in the epidemiology of AKI in
South Africa where older reports have not highlighted
trauma as a major cause of AKI [14, 15, 36] and has im-
portant public health implications for health administra-
tors. Sepsis was also a common precipitant of AKI at
40.6% which is similar to that reported in other LMI
country studies in the critically ill [1, 31, 37]. Herbal and
traditional medicine use is not a prominent cause of
AKI in our region compared with prior reports from
other regions [38, 39]. Tropical diseases such as malaria
are not endemic in our region and are therefore also not
common precipitants of AKI.
Severe AKI (KDIGO stage 3) was common, affecting
41.4% of all those with AKI and 24.4% of all admissions.
The number of patients dialyzed (10.4% of all admis-
sions) was slightly lower than in the large Acute Kidney
Injury–Epidemiologic Prospective Investigation (AKI-
EPI) study where 13.5% of all admissions were dialyzed
[1] and may be explained by local practice to usually
delay the initiation of dialysis until more classic indica-
tions exist. Notwithstanding this fact, most patients re-
quiring dialysis were initiated early (within 24 h of ICU
admission) reflecting the advanced state of organ dys-
function at admission and late presentation that is com-
mon in LMI countries [32]. Although the AKI-EPI study
was multinational, only 34 patients from Africa were in-
cluded. Continuous renal replacement therapies are avail-
able in our center but cost in excess of 10 times more
than intermittent dialysis. As such, CRRT is reserved for
specific indications and the rate of CRRT use was much
lower in our study at 13.6% compared to 75.2% in the
AKI-EPI study. Of those who developed AKI and survived,
a significant proportion of patients with stage 3 AKI did
not recover renal function fully (12.7%).
South Africa has a very high HIV burden of 7.9 million
people living with HIV as well as the largest number of
people on antiretroviral therapy in the world [40]. The
HIV seropositive rate of 32.6% in our cohort is consist-
ent with the known background prevalence of HIV in
our province of 25.2% in adults aged 15–49 when mea-
sured in 2018 [40]. This is vastly different to a retro-
spective study in a South African medical ICU in 2004
[41] where only three patients (6.5%) in the AKI cohort
were HIV positive. In our study, active tuberculosis was
very common, affecting 1 in 16 of all admissions. This is
likely in part due to the high prevalence of HIV, but also
due to the high reported background incidence of tuber-
culosis in the community of 1095 cases/100 000 per year
[42]. Whilst tuberculosis was not associated with AKI
per se, it was independently associated with mortality.
Many cases of active tuberculosis were diagnosed during
ICU admission through microbiological means and
many were not the primary cause of admission.
HIV infection was associated with higher mortality, as
well as the presence of sepsis and active tuberculosis. It
was also associated with increased severity of illness and
the need for emergency admission. Length of stay was
shorter for those with HIV, but reflects earlier mortality
in those with increased severity of illness. As in other
studies in the post-HAART era [36, 37, 43–45], it would
appear from our data that traditional predictors of mor-
tality such as higher severity of illness are implicated in
predicting mortality and not HIV status, CD4 count,
viral suppression nor the use of HAART.
Proportionally few (22.9%) HIV positive patients that
developed AKI were receiving Tenofovir-based HAART
at the time of ICU admission. Although there was little
difference in viral suppression between groups, the CD4
count was significantly lower in the group that devel-
oped AKI thereby placing patients at risk for the im-
mune reconstitution inflammatory syndrome (IRIS) [46].
While tenofovir has been shown to be nephrotoxic [47],
we hypothesize that the pathogenesis of AKI in at least
some of our HIV patients was related to the often recent
initiation of HAART with the development of an
unmasking tuberculosis-associated IRIS [48] and conse-
quent tuberculosis sepsis syndrome with associated AKI.
This has previously been reported [49] and is likely to be
under-recognized.
Study limitations and strengths
This study needs to be viewed in the context of its limi-
tations. We may have underestimated the incidence of
AKI since we were unable to reliably utilize the KDIGO
urine output criterion for diagnosis as patients admitted
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to the ICU were not always weighed or catheterised.
Secondly, 43.9% of all patients admitted to the ICU were
not tested for HIV. All patients who were able to con-
sent were encouraged to have an HIV test; however, pa-
tients that were moribund or confused were not tested
for HIV without indication or consent. On the other
hand, to our knowledge, this is the largest published
prospective cohort of critically ill adults with HIV and
AKI [50]. The study was inclusive of all major disciplines
with the exception of cardiothoracics and the loss to fol-
low up was low at 1.4%. Standardised criteria for the
diagnosis of all stages of AKI were used and 90-day renal
recovery data was obtained.
Conclusion
In this large prospective multidisciplinary ICU cohort of
younger patients in a LMI country with a high HIV
prevalence and many trauma related admissions, AKI
was frequently encountered, and was associated with a
high mortality, but good functional renal recovery in
most survivors. While HIV infection was associated with
higher mortality, this was due to increased severity of ill-
ness, not HIV status per se.
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